{"id":7461,"date":"2022-02-01T10:09:00","date_gmt":"2022-02-01T10:09:00","guid":{"rendered":"http:\/\/wordpress.p607267.webspaceconfig.de\/services\/"},"modified":"2022-04-13T10:42:26","modified_gmt":"2022-04-13T08:42:26","slug":"services","status":"publish","type":"page","link":"https:\/\/www.sanochemia.com\/en\/services\/","title":{"rendered":"Services"},"content":{"rendered":"

[vc_row padding_top_multiplier=”custom” padding_bottom_multiplier=”custom” rc_heading_color=”white” rc_link_color=”white” rc_link_hover_color=”white” rc_bg_type=”image” rc_bg_image=”7167″ rc_bg_color_overlay=”primary-1″ rc_bg_opacity_overlay=”80″ padding_top=”17%” padding_bottom=”17%” rc_font_color=”#ffffff” rc_bg_color=”#004189″][vc_column width=”1\/6″ vertical_content_position=”middle” tablet_width=”1-12″ tablet_sm_width=”hide” mobile_width=”hide”]

\r\n\t
\r\n\t\t\r\n\r\n
\r\n\t\t
\"\"<\/div><\/div>\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n[\/vc_column][vc_column width=”5\/6″ vertical_content_position=”middle” tablet_width=”11-12″ tablet_sm_width=”1″]

FOCUS ON QUALITY<\/span><\/h2>

Drug substance & drug product manufacturing from Austria<\/span><\/h1>[\/vc_column][\/vc_row][vc_row padding_top_multiplier=”6x” padding_bottom_multiplier=”5x” rc_bg_type=”image” rc_bg_image=”6474″ rc_bg_image_type=”parallax”][vc_column width=”1\/6″ tablet_width=”1-12″ tablet_sm_width=”hide”][\/vc_column][vc_column width=”5\/6″ tablet_sm_width=”1″]

Wide range of services<\/span><\/h4>

Because we put quality first<\/span><\/h3>[vc_column_text text_style=”leader-text”]With the development, production and distribution of pharmaceutical specialties, we have been contributing to people’s health for more than 30 years. Our strengths include the development and manufacture of sterile liquid dosage forms and small molecule active pharmaceutical ingredients. For our own needs and as CDMO for third parties. [\/vc_column_text]
<\/div>[\/vc_column][\/vc_row][vc_row padding_top_multiplier=”4x” padding_bottom_multiplier=”4x” rc_bg_type=”color” rc_bg_color=”#f9f9fa”][vc_column width=”1\/6″ tablet_width=”hide” tablet_sm_width=”hide” mobile_width=”hide”][\/vc_column][vc_column width=”5\/6″ tablet_width=”1″ tablet_sm_width=”1″][vc_row_inner columns_gap=”60″][vc_column_inner width=”1\/3″ animation=”fade-in-up” animation_delay=”100″]
\r\n\t
\r\n\t\t\r\n\r\n
\r\n\t\tMore<\/span>\t\t
\"\"<\/div><\/div>\t<\/a><\/div>\r\n\t<\/div>\r\n<\/div>\r\n
<\/div>
Imaging Agents<\/a><\/span><\/h6>[vc_column_text]In Austria, we develop, produce and distribute some of the most established generic imaging agents under the Sanochemia brand. Our products help physicians make efficient therapeutic decisions for patients.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″ animation=”fade-in-up” animation_delay=”300″]
\r\n\t
\r\n\t\t\r\n\r\n
\r\n\t\tMore<\/span>\t\t
\"\"<\/div><\/div>\t<\/a><\/div>\r\n\t<\/div>\r\n<\/div>\r\n
<\/div>
Contract Manufacturing<\/a><\/span><\/h6>[vc_column_text]With contract manufacturing of sterile and low-bioburden liquids as well as APIs, we offer in-depth expertise in the field of drug product and API production. As a full-service provider, we also support with GMP services.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″ animation=”fade-in-up” animation_delay=”500″]
\r\n\t
\r\n\t\t\r\n\r\n
\r\n\t\tMore<\/span>\t\t
\"\"<\/div><\/div>\t<\/a><\/div>\r\n\t<\/div>\r\n<\/div>\r\n
<\/div>
API<\/a><\/span><\/h6>[vc_column_text]Our focus on high-quality API synthesis completes our “made in Austria” offering. Innovative APIs for the treatment of muscle spasms and Alzheimer’s disease are produced and distributed by Sanochemia.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row height_ratio=”70″ padding_top_multiplier=”4x” padding_bottom_multiplier=”4x” rc_bg_type=”image” rc_bg_image=”6846″ rc_bg_image_type=”parallax” rc_bg_opacity_overlay=”20″ separator_bottom=”tilt-left-separator” separator_bottom_color=”#000000″ rc_bg_color=”#f9f9fa”][vc_column tablet_width=”hide” tablet_sm_width=”hide” mobile_width=”hide”][\/vc_column][\/vc_row][vc_row padding_top_multiplier=”5x” padding_bottom_multiplier=”4x” rc_bg_type=”color” separator_top_size=”60px” rc_bg_color=”#000000″][vc_column width=”1\/6″ tablet_sm_width=”hide” mobile_width=”hide”][\/vc_column][vc_column width=”5\/6″ content_width=”custom” tablet_sm_width=”1″ rc_font_color=”#999999″ grve_css=”{“desktop“:{“padding-right“:“50px“,“class“:“grve-wpb-1636554396940“}}” custom_content_width=”915px”]
TRUSTED PARTNER
\nFOR THE PHARMACEUTICAL INDUSTRY<\/span><\/h6>
Pharmaceutical specialties from Austria<\/span><\/span><\/h5>
<\/div>
We put our customers first. Are you looking for a
\ncompetent partner for your drug product or active ingredient production?<\/span><\/h5>
<\/div>
\r\n\t\tContact us today<\/span>\r\n\t\t\t\t\t\t\t<\/a><\/div>[\/vc_column][\/vc_row][vc_row padding_top_multiplier=”4x” padding_bottom_multiplier=”5x” separator_bottom=”tilt-left-separator” separator_bottom_size=”60px” separator_bottom_color=”#d0dde8″][vc_column]
Always remain up to date<\/span><\/h5>
\r\n\t
\r\n\t\t
<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\tSanochemia submits Marketing Authorization Application for USPIO Ferumoxtran in selected EU Member States<\/span><\/a>\r\n\t\t\t\t
\"\"<\/div><\/div>\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t

Sanochemia submits Marketing Authorization Application for USPIO Ferumoxtran in selected EU Member States<\/span><\/h2><\/a>\t\t\t\t
\r\n\t\t\t\t\t

Sanochemia submits a marketing authorization application (MAA) for Ferumoxtran under the decentralized procedure. The USPIO-based MRI contrast agent is intended for the detection and characterization of lymph node metastases in prostate cancer patients.\n<\/p>Read more<\/span>\t\t\t\t\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/a>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t\t\r\n\t\t\t\r\n\t\t\t

\r\n\t\t
\r\n\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\tSanochemia receives ALC Inclusion Award<\/span><\/a>\r\n\t\t\t\t
\"\"<\/div><\/div>\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t

Sanochemia receives ALC Inclusion Award<\/span><\/h2><\/a>\t\t\t\t
\r\n\t\t\t\t\t

In October 2025, Sanochemia Pharmazeutika was honored with the Austrian Leading Companies (ALC) Inclusion Award. This recognition highlights the company\u2019s longstanding commitment to fostering diversity, equal opportunities, and accessibility in the workplace.\n<\/p>Read more<\/span>\t\t\t\t\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/a>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t\t\r\n\t\t\t\r\n\t\t\t

\r\n\t\t
\r\n\t\t\t
\r\n\t
\r\n\t\t
\r\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\tSanochemia\/SPL: Investigational Iron-Based MRI Contrast Agent Meets Also Secondary Endpoints in Phase III<\/span><\/a>\r\n\t\t\t\t
\"\"<\/div><\/div>\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t

Sanochemia\/SPL: Investigational Iron-Based MRI Contrast Agent Meets Also Secondary Endpoints in Phase III<\/span><\/h2><\/a>\t\t\t\t
\r\n\t\t\t\t\t

The multicentric prospective PROSTAPROGRESS study on Ferumoxtran confirmed to meet also secondary endpoints. Post-hoc analysis showed elevated sensitivity and specificity data for metastatic lymph node lesions at levels surpassing the levels of current technologies.\n<\/p>Read more<\/span>\t\t\t\t\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t\t<\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/a>\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t\t<\/div>\r\n\t\t\t\r\n\t\t\t\r\n\t\t\t